Bacterial infection as a likely cause of adverse reactions to polyacrylamide hydrogel fillers in cosmetic surgery

Clinical Infectious Diseases

Volumn 56, Issue 10, 2013, Pages 1438-1444

  Christensen, Lise ^a   Breiting, Vibeke ^b   Bjarnsholt, Thomas ^c,d   Eickhardt, Steffen ^c   Høgdall, Estrid ^a   Janssen, Martin ^e   Pallua, Norbert ^f   Zaat, Sebastian A J ^g  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Holte Clinic of Plastic Surgery   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d Rigshospitalet   (Denmark)

^e Janssen Clinic of Plastic Surgery   (Netherlands)

^f UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

biofilm; foreign body infection; polyacrylamide gel filler

Indexed keywords

ANTIBIOTIC AGENT; FILLER; POLYACRYLAMIDE; RNA 16S;

ADULT; AGED; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BACTERIAL VIRULENCE; BACTERIUM CULTURE; CASE CONTROL STUDY; COMMENSAL; CONTROLLED STUDY; CYTOLOGY; ESTHETIC SURGERY; FEMALE; GENE SEQUENCE; HISTOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFECTION COMPLICATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPIONIBACTERIUM ACNES; SOFT TISSUE; STAPHYLOCOCCUS EPIDERMIDIS;

ACRYLIC RESINS; ADULT; AGED; BACTERIA; BACTERIAL INFECTIONS; BIOFILMS; BIOPSY; CASE-CONTROL STUDIES; COSMETIC TECHNIQUES; FEMALE; HAND; HISTOCYTOCHEMISTRY; HUMANS; HYDROGELS; LIP; MALE; MIDDLE AGED; PROSTHESES AND IMPLANTS; SURGERY, PLASTIC;

EID: 84877251404     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit067     Document Type: Article

References (24)

1. Christensen L, Breiting V, Janssen M, Vuust J, Hogdall E. Adverse reactions to injectable soft tissue permanent fillers. Aesth Plast Surg 2005; 29:34-48.
2. Christensen L. Normal and pathologic tissue reactions to soft tissue gel fillers. Dermatol Surg 2007; 33(suppl 2):S168-75.
3. Christensen LH. Host tissue interaction, fate, and risks of degradable and nondegradable gel fillers. Dermatol Surg 2009; 35(suppl 2): 1612-9.
4. US Food and Drug Administration. MAUDE-manufacturer and user facility device experience. Available at: http://www.accessdata.fda.gov/scripts/cdrh/ cfdocs/cfMAUDE/search.CFM. Accessed 31 January 2013.
5. Pallua N, Wolter T. A 5-year assessment of safety and aesthetic results after facial soft-tissue augmentation with polyacrylamide hydrogel (Aquamid): a prospective multicenter study of 251 patients. Plast Reconstr Surg 2010; 125:1797-804.
6. Lowe NJ, Maxwell CA, Lowe P, Shah A, Patnaik R. Injectable polyl-lactic acid: 3 years of aesthetic experience. Dermatol Surg 2009; 35(suppl 1):344-9.
7. Cohen SR, Berner CF, Busso M, et al. ArteFill: a long-lasting injectable wrinkle filler material-summary of the U.S. Food and Drug Administration trials and a progress report on 4-to 5-year outcomes. Plast Reconstr Surg 2006; 118(suppl 3):64S-76S.
8. Ceresana. Market study: fillers. 2nd ed. Available at: www.ceresana. com/en/market-studies/additives/fillers-new. Accessed 1 February 2013.
9. Lemperle G, Rullan PP, Gauthier-Hazan N. Avoiding and treating dermal filler complications. Plast Reconstr Surg 2006; 118(suppl 3): 92-107.
10. Cohen JL. Understanding, avoiding, and managing dermal filler complications. Dermatol Surg 2008; 34(suppl 1):S92-9.
11. Reisberger EM, Landthaler M, Wiest L, Schröder J, Stolz W. Foreign body granulomas caused by polymethylmethacrylate microspheres: successful treatment with allopurinol. Arch Dermatol 2003; 139:17-20.
12. Stewart DB, Morganroth GS, Mooney MA, Cohen JM, Levin PS, Gladstone HB. Management of visible granulomas following periorbital injection of poly-L-lactic acid. Ophthal Plast Reconstr Surg 2007; 23:298-301.
13. Christensen L, Breiting V, Vuust J, Hogdall E. Adverse reactions following injection with a permanent facial filler polyacrylamide hydrogel (Aquamid): causes and treatment. Eur J Plast Surg 2006; 28: 464-71.
14. Bjarnsholt T, Tolker-Nielsen T, Givskov M, Janssen M, Christensen LH. Detection of bacteria by fluorescence in situ hybridization in culture-negative soft tissue filler lesions. Dermatol Surg 2009(suppl 2); 35:1620-24.
15. Dayan SH, Arkins JP, Brindise R. Soft tissue fillers and biofilms. Facial Plast Surg 2011; 27:23-8.
16. Sánchez O, Rodríguez-Sureda V, Domínguez C, et al. Study of biomaterial-induced macrophage activation, cell-mediated immune response and molecular oxidative damage in patients with dermal bioimplants. Immunobiology 2012; 217:44-53.
17. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 1999; 284:1318-22.
18. Brahm J, Lessel R, Ditlev S, Schmidt R. Flux of selected body fluid constituents and benzylpenicillin in polyacrylamide hydrogel (PAAG). J Tissue Eng Regen Med 2012 ;6:793-802.
19. Anderson JM. Biomaterials science. An introduction to materials in medicine. San Diego, CA: Elsevier, 296-304, 2004.
20. Boelens JJ, Dankert J, Murk JL, et al. Biomaterial-associated persistence of Staphylococcus epidermidis in pericatheter macrophages. J Infect Dis 2000; 18:1337-49.
21. Broekhuizen CAN, Schultz MJ, van der Wal AC, et al. Tissue around catheters is a niche for bacteria associated with medical device infection. Crit Care Med 2008; 36:2395-2402.
22. Broekhuizen CA, de Boer L, Schipper K, et al. Staphylococcus epidermidis is cleared from biomaterial implants but persists in peri-implant tissue in mice despite rifampicin/vancomycin treatment. J Biomed Mater Res A 2008; 85:498-505.
23. Sapolsky RM, Romero LM, Munck AU. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocr Rev 2000; 21:55-89.
24. Rainsford KD. Anti-inflammatory drugs in the 21st century. Subcell Biochem 2007; 42:3-27.